Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

Axplora is investing several million euros to expand lyophilisation capacity [...]

Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]

Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]

Ona Therapeutics has appointed Antoine Yver as chair of its [...]

Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

Myricx Bio has appointed Boston-based Mohit Rawat as chief executive [...]

Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]

Contract manufacturer Symbiosis Pharmaceutical Services has announced the completion of [...]

The former ASCO president shares his insights on breast cancer [...]